The cardiovascular assessment extends beyond the clinical setting, involving a holistic approach that considers lifestyle factors, family history, and social determinants of health. Risk factor identification, such as assessing lipid profiles, blood glucose levels, and body mass index (BMI), plays a crucial role in determining an individual's susceptibility to cardiovascular diseases. Additionally, behavioral factors such as tobacco use, physical activity, and dietary habits are key components of the assessment, as they significantly influence cardiovascular health. Regular cardiovascular assessments are essential for individuals with chronic conditions, such as hypertension or diabetes, to monitor and manage their cardiovascular risk factors effectively. Periodic screenings and preventive measures contribute to the early detection of cardiovascular issues, enabling timely interventions and promoting overall heart health. The comprehensive nature of cardiovascular assessment underscores its significance in both preventive care and the management of cardiovascular diseases, fostering a proactive and patient-centered approach to cardiovascular health.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India